Franklin O. Smith

8.7k total citations · 2 hit papers
121 papers, 5.3k citations indexed

About

Franklin O. Smith is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Franklin O. Smith has authored 121 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 40 papers in Public Health, Environmental and Occupational Health and 33 papers in Molecular Biology. Recurrent topics in Franklin O. Smith's work include Acute Myeloid Leukemia Research (58 papers), Hematopoietic Stem Cell Transplantation (39 papers) and Acute Lymphoblastic Leukemia research (37 papers). Franklin O. Smith is often cited by papers focused on Acute Myeloid Leukemia Research (58 papers), Hematopoietic Stem Cell Transplantation (39 papers) and Acute Lymphoblastic Leukemia research (37 papers). Franklin O. Smith collaborates with scholars based in United States, Canada and Spain. Franklin O. Smith's co-authors include Todd A. Alonzo, Nita L. Seibel, Gregory H. Reaman, Robert B. Gerbing, Sean F. Altekruse, Alan S. Gamis, Malcolm A. Smith, Maura O’Leary, Lynn A. G. Ries and Beverly J. Lange and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Franklin O. Smith

117 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

2010 744 citations Franklin O. Smith, Gregory H. Reaman et al. Journal of Clinical Oncology profile →
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

2014 313 citations Alan S. Gamis, Todd A. Alonzo et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Franklin O. Smith United States	37	2.9k	1.8k	1.5k	1.2k	877	121	5.3k
Keizo Horibe Japan	45	3.1k 1.1×	2.7k 1.5×	1.4k 0.9×	1.6k 1.3×	1.5k 1.7×	282	6.7k
Michael Dworzak Austria	45	3.6k 1.2×	3.0k 1.7×	1.2k 0.8×	1.2k 1.0×	1.0k 1.2×	189	5.8k
Shai Izraeli Israel	42	1.7k 0.6×	1.9k 1.1×	2.6k 1.7×	885 0.7×	967 1.1×	176	5.7k
Frederick G. Behm United States	43	3.7k 1.3×	3.8k 2.1×	2.1k 1.4×	1.5k 1.2×	1.7k 1.9×	98	7.6k
Kristen E. Stevenson United States	35	3.4k 1.2×	1.5k 0.9×	1.9k 1.2×	1.4k 1.1×	1.1k 1.2×	128	7.2k
Georg Mann Austria	39	2.2k 0.7×	2.6k 1.5×	781 0.5×	1.0k 0.8×	1.2k 1.3×	147	4.5k
Masahiro Tsuchida Japan	34	2.9k 1.0×	1.2k 0.7×	736 0.5×	963 0.8×	503 0.6×	160	4.3k
Elizabeth Macintyre France	44	2.8k 1.0×	2.4k 1.3×	1.9k 1.2×	1.5k 1.2×	666 0.8×	237	7.7k
Hélène Espérou France	36	2.9k 1.0×	925 0.5×	743 0.5×	843 0.7×	700 0.8×	90	4.6k
Yasuhide Hayashi Japan	45	2.9k 1.0×	1.3k 0.7×	4.1k 2.6×	917 0.7×	324 0.4×	226	7.1k

Countries citing papers authored by Franklin O. Smith

Since Specialization

Citations

This map shows the geographic impact of Franklin O. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franklin O. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franklin O. Smith more than expected).

Fields of papers citing papers by Franklin O. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franklin O. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franklin O. Smith. The network helps show where Franklin O. Smith may publish in the future.

Co-authorship network of co-authors of Franklin O. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Franklin O. Smith. A scholar is included among the top collaborators of Franklin O. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franklin O. Smith. Franklin O. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gamis, Alan S., Todd A. Alonzo, Soheil Meshinchi, et al.. (2014). Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531. Journal of Clinical Oncology. 32(27). 3021–3032. 313 indexed citations breakdown →

Gamis, Alan S., Richard Aplenc, Todd A. Alonzo, et al.. (2013). Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531. Blood. 122(21). 355–355. 11 indexed citations

Alonzo, Todd A., Robert B. Gerbing, Samir B. Kahwash, et al.. (2013). Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report. Blood. 122(21). 612–612. 9 indexed citations

Brown, Patrick A. & Franklin O. Smith. (2008). Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia. Pediatric Drugs. 10(2). 85–92. 6 indexed citations

Shenoy, Shalini & Franklin O. Smith. (2008). Hematopoietic stem cell transplantation for childhood malignancies of myeloid origin. Bone Marrow Transplantation. 41(2). 141–148. 12 indexed citations

Elder, Deborah A., David A. D’Alessio, Ori Eyal, et al.. (2008). Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion. Pediatric Blood & Cancer. 51(2). 256–260. 28 indexed citations

Puumala, Susan E., Julie A. Ross, Andrew F. Olshan, et al.. (2007). Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome. Cancer. 110(9). 2067–2074. 23 indexed citations

Ross, Julie A., Cindy K. Blair, Andrew F. Olshan, et al.. (2005). Periconceptional vitamin use and leukemia risk in children with Down syndrome. Cancer. 104(2). 405–410. 31 indexed citations

Hilden, Joanne M., Patricia A. Dinndorf, Sharon O. Meerbaum, et al.. (2005). CCG 1953: Acute Lymphoblastic Leukemia in Infants: Analysis of Prognostic Factors: A Report from the Children’s Oncology Group.. Blood. 106(11). 7–7. 4 indexed citations

10.

Woods, Erik J., Jun Liu, Karen E. Pollok, et al.. (2003). A Theoretically Optimized Method for Cord Blood Stem Cell Cryopreservation. Journal of Hematotherapy & Stem Cell Research. 12(3). 341–350. 17 indexed citations

11.

Feusner, James H., Todd A. Alonzo, Patricia A. Dinndorf, Franklin O. Smith, & R.J. Arceci. (2002). Infectious complications of intensive chemotherapy on children's cancer group protocol CCG-2961 for pediatric acute myeloid leukemia. Blood. 100(11). 4 indexed citations

12.

Smith, Franklin O., Roberta King, Gene Nelson, et al.. (2002). Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. British Journal of Haematology. 116(3). 716–724. 51 indexed citations

13.

Woods, Erik J., et al.. (2000). Cutting Edge Communication: Osmometric and Permeability Characteristics of Human Placental/Umbilical Cord Blood CD34T ⁺ Cells and Their Application to Cryopreservation. Journal of Hematotherapy & Stem Cell Research. 9(2). 161–173. 57 indexed citations

14.

Dagher, Ramzi, Susan G. Kreissman, Kent A. Robertson, et al.. (1998). High Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell Transplantation in an Anephric Child With Multiply Recurrent Wilms Tumor. Journal of Pediatric Hematology/Oncology. 20(4). 357–360. 12 indexed citations

15.

Sievers, Eric L., Beverly J. Lange, Jonathan D. Buckley, et al.. (1996). Prediction of Relapse of Pediatric Acute Myeloid Leukemia by Use of Multidimensional Flow Cytometry. JNCI Journal of the National Cancer Institute. 88(20). 1483–1488. 67 indexed citations

16.

Smith, Franklin O., Wendy H. Raskind, Philip J. Fialkow, & Irwin D. Bernstein. (1995). Cellular Biology of Acute Myelogenous Leukemia. Journal of Pediatric Hematology/Oncology. 17(2). 113–122. 5 indexed citations

17.

Sorensen, P H, C S Chen, Franklin O. Smith, et al.. (1994). Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.. Journal of Clinical Investigation. 93(1). 429–437. 124 indexed citations

18.

Bishop, Ann Peterson, D Arthur, Carolina Are, et al.. (1967). PAR volume 57 issue 4 Cover and Front matter. Parasitology. 57(4). f1–f9. 1 indexed citations

19.

Bishop, Ann Peterson, D Arthur, Carolina Are, et al.. (1967). PAR volume 57 issue 2 Cover and Front matter. Parasitology. 57(2). f1–f9. 1 indexed citations

20.

Bishop, Ann Peterson, D Arthur, Carolina Are, et al.. (1967). PAR volume 57 issue 3 Cover and Front matter. Parasitology. 57(3). f1–f9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact